Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-alpha and oseltamivir for influenza A
NCT01146535Phase 2Completed
- Sponsor
- Ainos, Inc.
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A virus infection (IAV) comparing Interferon-alpha + Oseltamivir with Placebo + Oseltamivir (2 arms). Primary endpoint: Resolution of fever and flu symptoms at 5 days. Started Jan 2011; status: completed.
02
Drugs
veldona
03
Conditions
Influenza A virus infection (IAV)
Beyond the preview
Go deeper on NCT01146535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146535.